Tamtuvetmab

• CAS Number :

  1608122-71-9

• Target :

  NF-?B

• Related Pathways :

  NF-?B

• Bioactivity :

  Tamtuvetmab (AT-005), a caninised version of blontuvetmab targeting CD52, enhances progression-free survival (PFS) and demonstrates in vivo efficacy for treating naïve T-cell lymphoma (LSA) in dogs. The compound has received veterinary approval [1] [2].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C